Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 6,825 | 5,783 | 4,208 | 2,514 | 1,175 |
| Cost of Goods | 1,797 | 1,683 | 3,676 | 757 | 528 |
| Gross Profit | 5,028 | 4,100 | 532 | 1,757 | 647 |
| Operating Expenses | 29,222 | 30,236 | 32,031 | 29,482 | 28,999 |
| Operating Income | -23,397 | -25,453 | -30,823 | -26,968 | -27,824 |
| Other Income | -17,547 | -12,308 | 100 | 114 | 107 |
| Pre-tax Income | -40,944 | -37,761 | -30,723 | -26,854 | -27,717 |
| Income Tax | 20 | 23 | 22 | 23 | 22 |
| Net Income Continuous | -40,964 | -37,784 | -30,745 | -26,877 | -27,739 |
| Net Income | $-40,964 | $-37,784 | $-30,745 | $-26,877 | $-27,739 |
| EPS Basic Total Ops | -0.39 | -0.36 | -0.29 | -0.26 | -0.28 |
| EPS Basic Continuous Ops | -0.39 | -0.36 | -0.29 | -0.26 | -0.28 |
| EPS Diluted Total Ops | -0.39 | -0.36 | -0.29 | -0.26 | -0.28 |
| EPS Diluted Continuous Ops | -0.39 | -0.36 | -0.29 | -0.26 | -0.28 |
| EBITDA(a) | $-7,449 | $-13,992 | $-30,735 | $-26,865 | $-27,686 |